Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Astaxanthin: A potential mitochondrial-targeted antioxidant treatment in diseases and with aging
Administered as a subcutaneous weekly injection, it is a manifold single pharmacological agent that has the ability to significantly lower glucose levels, as well as improve insulin sensitivity, reduce weight and amend dyslipidemia favorably modifying the lipid profile
Healthy eating and regular movement help these medications work at their best
Improved lipid profile: Reduces triglycerides while increasing HDL/LDL ratio
Known hypersensitivity to enclomiphene or related compounds (e.g., clomiphene)
Vial initiates phase 1 trial of Vials INHBE siRNA for the treatment of obesity
US$ 28.38
US$ 28.17
US$ 28.79
US$ 22.43
